FDA-approved drug helps treat rare immunologic disease, study finds
Credit: NIAID WHAT: Adding the injectable drug mepolizumab to standard treatment for eosinophilic granulomatosis with polyangiitis (EGPA), a rare immunologic disease, significantly improved clinica..
















